Johnson and Johnson Joins Hand with Telangana-based Biological E to Manufacture Covid Vaccine
3 years, 7 months ago

Johnson and Johnson Joins Hand with Telangana-based Biological E to Manufacture Covid Vaccine

News 18  

US pharmaceutical company Johnson and Johnson has joined hands with Telangana-based Biological E Limited for the manufacturing of the COVID-19 vaccine. We believe Biological E. will be an important part of our global COVID-19 vaccine supply network, where multiple manufacturing sites are involved in the production of our vaccine across different facilities, sometimes in different countries and continents, before the vaccine can be distributed,” an official statement by Johnson and Johnson said on Tuesday, ANI reported. The statement from Johnson and Johnson also said that the company is working around the clock to develop and broadly activate our manufacturing capabilities to supply our COVID-19 vaccine worldwide. The pharma giant said that it is in discussions with the Government of India to start bridging clinical study of Janssen Covid-19 vaccine candidate in India, subject to regulatory approvals.

India Johnson Covid Biological Vaccine Janssen  johnson  vaccine  covid19  statement  manufacture  named  working  biological  supply  joins  limited  hand  manufacturing  telanganabased  covid

History of this topic

Johnson & Johnson wants to shutter Leiden vaccine lab; cut jobs
1 year, 4 months ago

Johnson & Johnson wants to shutter Leiden vaccine lab; cut jobs

NL Times  

The Leiden pharmaceutical company Janssen intends to largely close its vaccine department because the American parent company Johnson & Johnson wants to focus more on other, new treatment methods. In 2021, then coronavirus minister Hugo de Jonge promoted the vaccine with the slogan “Dance with Janssen.” Many young people responded. But, in the following weeks, that led to many coronavirus …

Ebola vaccines produced lasting antibodies during trial: Studies
2 years ago

Ebola vaccines produced lasting antibodies during trial: Studies

Al Jazeera  

Studies in West Africa said that the vaccines developed by Johnson & Johnson and Merck & Co appear to be safe in children and adults. Ebola vaccines developed by Johnson & Johnson and Merck & Co produced virus-fighting antibodies and appear to be safe in children and adults, according to data from two studies conducted in West Africa. Both companies’ …

Africa's COVID vaccine production line in jeopardy
2 years, 7 months ago

Africa's COVID vaccine production line in jeopardy

The Hindu  

Trisha shakes her head when asked if she's vaccinated. 'A massive setback for Africa's plans' In the absence of orders or commitments, Aspen is considering the repurposing of two COVID-19 production lines for the manufacture of other products. "The continent would lose its only existing COVID vaccine manufacturing capacity," Nicolaou says. Africa's major public health body, the Africa Centers for …

FDA restricts Johnson & Johnson’s COVID-19 vaccine due to blood clot risk
2 years, 7 months ago

FDA restricts Johnson & Johnson’s COVID-19 vaccine due to blood clot risk

LA Times  

Vials of the Johnson & Johnson COVID-19 vaccine are seen at a pharmacy in 2021. U.S. regulators on Thursday strictly limited who can receive Johnson & Johnson’s COVID-19 vaccine due to the ongoing risk of rare but serious blood clots. FDA officials said in a statement that they decided to restrict J&J’s vaccine after taking another look at data on …

Biological E. to receive mRNA vaccine tech from WHO
2 years, 8 months ago

Biological E. to receive mRNA vaccine tech from WHO

The Hindu  

Vaccine maker Biological E. has been selected to receive mRNA technology from the World Health Organization technology transfer hub. After examining a number of proposals from India, the WHO's Advisory Committee on Vaccine Product Development has selected Biological E. as a recipient, the Hyderabad–based firm said on Monday. The company has been investing in mRNA technologies since last year and …

Inside Story of How India Got Its Own Covid Vaccine, Did Not Succumb to Bullying by Foreign Firms
2 years, 9 months ago

Inside Story of How India Got Its Own Covid Vaccine, Did Not Succumb to Bullying by Foreign Firms

News 18  

Speaking of vaccine development, never before has India incubated companies by engaging in proactive risk financing on a scale as enormous as this. NEGVAC’s vaccination strategy was based on two components: the information coming in simultaneously from the manufacturers that vaccine availability would be limited in the first six months due to restrictions in their capacities. At the same time, …

The big vaccine pivot: Merck falters on Covid-19 shots, then makes one for rival
3 years ago

The big vaccine pivot: Merck falters on Covid-19 shots, then makes one for rival

Live Mint  

Weeks after Merck & Co. scrapped development of its Covid-19 vaccines in January, one of its senior manufacturing officials began phoning his deputies, telling them their work on a pandemic shot wasn’t actually over. J&J’s unusual collaboration with a rival, and Merck’s speedy manufacturing run-up, reflect one of the biggest challenges of the pandemic: making enough Covid-19 vaccines to meet …

Omicron: Vaccine nationalism will only perpetuate the pandemic
3 years ago

Omicron: Vaccine nationalism will only perpetuate the pandemic

Al Jazeera  

The United Kingdom and wealthy European nations are in a panic. For more than a year, the UK and European Union have blocked a proposal from South Africa and India to suspend intellectual property on COVID -19 technologies including vaccines. But South Africa’s lingering apartheid-era health system, enduring levels of poverty, and year-long inability to obtain decent amounts of vaccines …

Covid-19: J&J's Hyderabad-made Jabs Get CDL Nod, Over 1 Cr Doses Ready for Export
3 years, 1 month ago

Covid-19: J&J's Hyderabad-made Jabs Get CDL Nod, Over 1 Cr Doses Ready for Export

News 18  

American pharma giant Johnson & Johnson’s Covid-19 vaccine shots, manufactured in India by Hyderabad-based Biological E, are ready for export, News18.com learnt. “Once the Drug Controller General of India approves the report sent by CDL and the request filed by the company, the batches can be exported.” The move is in line with Prime Minister Narendra Modi’s announcement at the …

Month On, Johnson & Johnson’s Covid Vaccines Stuck at Kasauli Lab Over Pending Data from Indian Maker
3 years, 2 months ago

Month On, Johnson & Johnson’s Covid Vaccines Stuck at Kasauli Lab Over Pending Data from Indian Maker

News 18  

American pharma giant Johnson & Johnson’s Covid-19 vaccine shots, manufactured in India by Hyderabad-based Biological E, are stuck at the country’s apex vaccine testing laboratory in Himachal Pradesh due to pending data, News18.com has learnt. The batch of around 35 lakh vaccine doses, which arrived at the Central Drugs Laboratory in Kasauli over a month ago, are lying at the …

India may try to find 'middle ground' for usage and export of J&J single-shot jab
3 years, 2 months ago

India may try to find 'middle ground' for usage and export of J&J single-shot jab

Firstpost  

A strategy needs to be put in place where India may take a share of the monthly production of J&J’s vaccine for domestic use, said a senior government official privy to developments on this front The Indian government may initiate a fresh round of talks with Johnson & Johnson to find a middle ground on domestic usage and export of …

Two dose version of Johnson & Johnson shot 94% effective against Covid-19, study finds
3 years, 3 months ago

Two dose version of Johnson & Johnson shot 94% effective against Covid-19, study finds

CNN  

CNN — A two-dose version of Johnson & Johnson’s coronavirus vaccine provides 94% protection against symptomatic infection, the company said Tuesday – making a two-dose regimen of J&J’s Janssen vaccine comparable to a two-dose regimen of Moderna’s or Pfizer’s. “Our large real-world-evidence and Phase 3 studies confirm that the single-shot Johnson & Johnson vaccine provides strong and long-lasting protection against …

Made by Biological E, J&J's Single-Shot Covid Vaccine to Hit Market Next Month
3 years, 3 months ago

Made by Biological E, J&J's Single-Shot Covid Vaccine to Hit Market Next Month

News 18  

US Pharma giant Johnson & Johnson’s single shot vaccine manufactured by Hyderabad-based Biological E is likely to be rolled out by October, News18.com has learnt. The vaccine batches are expected to go for the final testing at the apex laboratories — Central Drugs Laboratory, Kasauli and National Centre for Cell Science, Pune — by next week. “The vaccine is likely …

Biological E's ‘Corbevax’ gets DCGI approval for two clinical trials
3 years, 3 months ago

Biological E's ‘Corbevax’ gets DCGI approval for two clinical trials

Hindustan Times  

The Drugs Controller General of India has given approval to Biological E for two clinical trials of its Covid-19 vaccine candidate Corbevax, the ministry of science and technology announced Friday. The Hyderabad-based pharmaceutical company received approval for Phase 3 comparator safety and immunogenicity trial in adults after a review of Phase 1 and 2 clinical trials data by a subject …

EU to return millions of doses of J&J’s Covid-19 vaccine imported from Africa
3 years, 3 months ago

EU to return millions of doses of J&J’s Covid-19 vaccine imported from Africa

Live Mint  

The European Union will return to Africa millions of doses of Johnson & Johnson’s Covid-19 vaccine that it received from a plant in South Africa, following criticism by health activists that the bloc was taking away shots from a continent that has the lowest immunization rate in the world. Strive Masiyiwa, who heads the African Union’s Vaccine Acquisition Task Team, …

South Africa will no longer send J&J vaccines to Europe, AU envoy says
3 years, 3 months ago

South Africa will no longer send J&J vaccines to Europe, AU envoy says

CNN  

CNN — An arrangement in which Johnson & Johnson Covid-19 vaccines were being shipped from South Africa to Europe has been suspended, African Union Special Envoy for Covid-19 response, Strive Masiyiwa, has said. The arrangement was reversed in part due to interventions from South African President Cyril Ramaphosa, European Commission President Ursula von der Leyen, and French President Emmanuel Macron, …

Johnson & Johnson files application to test its COVID vaccine on adolescents; all you need to know
3 years, 4 months ago

Johnson & Johnson files application to test its COVID vaccine on adolescents; all you need to know

Firstpost  

The US-based pharmaceutical company noted that it is committed to facilitating global equitable access to its COVID-19 vaccine and recognise the unmet needs of children Johnson & Johnson Friday said it has submitted an application to the Indian drug regulator to conduct a study of its COVID-19 vaccine in adolescents aged 12-17 years. The US-based pharmaceutical company noted that it …

Johnson and Johnson seeks nod for vaccine trials on 12-17 age group
3 years, 4 months ago

Johnson and Johnson seeks nod for vaccine trials on 12-17 age group

The Hindu  

U.S. pharma major Johnson & Johnson has applied for permission to conduct clinical trials of its single-shot COVID-19 vaccine on adolescents aged 12-17 years in India. J&J India spokesperson in a statement said: “We are committed to facilitating global equitable access to its COVID-19 vaccine and recognise the unmet needs of children. On August 17, 2021, we submitted an application …

J&J Applies for Covid-19 Vaccine Study in Indian Adolescents
3 years, 4 months ago

J&J Applies for Covid-19 Vaccine Study in Indian Adolescents

News 18  

Johnson & Johnson on Friday said it has submitted an application to the Indian drug regulator to conduct a study of its COVID-19 vaccine in adolescents aged 12-17 years. “On August 17, 2021, we submitted an application to the Central Drugs Standard Control Organisation to conduct a study of the Johnson & Johnson COVID-19 vaccine in India in adolescents aged …

South African activists slam J&J for exporting vaccines
3 years, 4 months ago

South African activists slam J&J for exporting vaccines

Associated Press  

JOHANNESBURG — Health activists in Africa have slammed Johnson & Johnson for exporting vaccines produced in South Africa to countries in Europe, which have already immunized large numbers of their people and have even donated vaccines to more needy countries. The South African activists on Tuesday called for a full disclosure of the South African government’s contracts with Johnson & …

News18 Evening Digest: Johnson & Johnson's Single-Dose Covid-19 Vaccine Gets Approval in India and Other Top Stories
3 years, 4 months ago

News18 Evening Digest: Johnson & Johnson's Single-Dose Covid-19 Vaccine Gets Approval in India and Other Top Stories

News 18  

Johnson & Johnson?s Jab Added to List: India Now Has 5 Vaccines for Adults, All You Need to Know Johnson and Johnson?s single-dose Covid-19 vaccine has been given approval for emergency use in India. 50 People Arrested, Over 150 Booked in Pakistan for Attack on Hindu Temple Pakistan’s law enforcement agencies on Saturday arrested over 50 people, including the main …

Johnson & Johnson's single-dose COVID-19 vaccine gets Emergency Use approval in India for adult population
3 years, 4 months ago

Johnson & Johnson's single-dose COVID-19 vaccine gets Emergency Use approval in India for adult population

Firstpost  

J&J earlier had sought approval to conduct phase-3 clinical trial of its vaccine on approximately 600 participants in two age groups—those aged 18 and below 60 years and those aged 60 years and above—to evaluate the safety, reactogenicity and immunogenicity of the jab in healthy Indian adults. Johnson & Johnson’s single-dose COVID-19 vaccine has been given Emergency Use approval in …

Johnson and Johnson’s single-dose COVID-19 vaccine approved for emergency use in India
3 years, 4 months ago

Johnson and Johnson’s single-dose COVID-19 vaccine approved for emergency use in India

The Hindu  

Johnson and Johnson’s single-dose COVID-19 vaccine was on Saturday given approval for Emergency Use Authorisation in India, making it the 5th COVID vaccine to get the clearance in the country. It further said the Central Drugs Standard Control Organisation had granted permission to conduct the phase I clinical trial of intranasal adenoviral vector COVID-19 vaccine to Bharat Biotech International Limited, …

Johnson & Johnson gets EUA in India: Here's your ultimate guide to the single-dose vaccine
3 years, 4 months ago

Johnson & Johnson gets EUA in India: Here's your ultimate guide to the single-dose vaccine

Firstpost  

The vaccine was 66.3 percent effective in clinical trials at preventing laboratory-confirmed COVID-19 infection in people who received the vaccine and had no evidence of being previously infected Global healthcare major Johnson & Johnson on Saturday received Emergency Use Authorization for its single-dose COVID-19 vaccine in India, Union Health Minister Mansukh Mandaviya tweeted. The Johnson & Johnson vaccine, known as …

Johnson & Johnson Applies for Emergency Approval of Its Single-dose Covid Vaccine in India
3 years, 4 months ago

Johnson & Johnson Applies for Emergency Approval of Its Single-dose Covid Vaccine in India

News 18  

Global healthcare major Johnson & Johnson on Friday said it has applied for Emergency Use Authorization of its single-dose COVID-19 vaccine in India. Earlier on Monday, the company had said that it remained committed to bringing its single-dose COVID-19 vaccine to India and looks forward to ongoing discussions with the Indian government. "On August 5, 2021 Johnson & Johnson Pvt …

Johnson & Johnson applies for approval of its single-dose Covid-19 vaccine in India
3 years, 4 months ago

Johnson & Johnson applies for approval of its single-dose Covid-19 vaccine in India

India TV News  

Global healthcare major Johnson & Johnson on Friday said it has applied for Emergency Use Authorization of its single-dose COVID-19 vaccine in India. Earlier on Monday, the company had said that it remained committed to bringing its single-dose COVID-19 vaccine to India and looks forward to ongoing discussions with the Indian government. "On August 5, 2021 Johnson & Johnson Pvt …

Johnson & Johnson applies for approval of its single-dose Covid vaccine in India
3 years, 4 months ago

Johnson & Johnson applies for approval of its single-dose Covid vaccine in India

Hindustan Times  

Johnson & Johnson, the 134-year-old American pharma conglomerate, has now applied to the Central Drug Standard Control Organisation of India seeking emergency use approval of its single-shot vaccine. Johnson & Johnson has approached the Central Drug Standard Control Organisation for Emergency Use Authorization for the single-dose Covid-19 vaccine "This is an important milestone that paves the way to bringing our …

Johnson & Johnson says talks with India on Covid vaccine Janssen still going on
3 years, 4 months ago

Johnson & Johnson says talks with India on Covid vaccine Janssen still going on

Hindustan Times  

Days after India's drugs regulator announced that Johnson & Johnson has pulled out its proposal seeking accelerated approval of its Covid-19 vaccine, the company said that the talks are still on. A health worker prepares a dose of Janssen Johnson & Johnson Covid-19 vaccine at Leopold Sedar Senghor stadium in Dakar, Senegal. Without giving any details, Central Drugs Standard Control …

J&J Says Still in Talks With India On Vaccine; All You Need to Know About Janssen
3 years, 4 months ago

J&J Says Still in Talks With India On Vaccine; All You Need to Know About Janssen

News 18  

US-based pharmaceutical company Johnson & Johnson said on Monday it was still in talks with the Indian government over its COVID-19 vaccine after the country’s drug regulator announced the company had pulled its proposal seeking an accelerated approval for local trials. “We look forward to ongoing discussions with the Government of India and will continue to explore how to accelerate …

Johnson & Johnson Withdraws Proposal for Speedy Covid Vaccine Approval in India
3 years, 4 months ago

Johnson & Johnson Withdraws Proposal for Speedy Covid Vaccine Approval in India

News 18  

The Central Drugs Standard Control Organisation said on Monday that Johnson & Johnson withdrew its proposal seeking accelerated approval of its COVID-19 vaccine in the country, without giving additional details. The drugmaker's withdrawal comes as India tackles legal challenges with manufacturers over indemnity issues, with its junior health minister saying last week that a team had been formed to engage …

FDA is letting troubled COVID vaccine factory restart, company says
3 years, 4 months ago

FDA is letting troubled COVID vaccine factory restart, company says

LA Times  

A vial of Johnson & Johnson’s COVID-19 vaccine is used at a pop-up clinic in the Staten Island. The U.S. Food and Drug Administration is allowing the problem-plagued factory of contract manufacturer Emergent BioSolutions to resume production of COVID-19 vaccine, the company said Thursday. The lapses at the Bayview factory have hampered J&J’s efforts to be a major player in …

Biological E’s Covid Vaccine 'Corbevax' Likely To be Launched By September End
3 years, 4 months ago

Biological E’s Covid Vaccine 'Corbevax' Likely To be Launched By September End

ABP News  

Hyderabad: Pharmaceutical company Biological E is expected to launch its Covid-19 vaccine 'Corbevax' by September end in the country. The report claimed that the government has already booked Biological E's COVID-19 vaccine Corbevax which is currently in advance phase 3 clinical trials for 'at-risk manufacturing' of the COVID-19 vaccine. Union Minister of State for Health, Dr Bharati Pravin Pawar recentky …

Vaccine inequalty: African countries to receive six million Johnson and Johnson vaccines
3 years, 5 months ago

Vaccine inequalty: African countries to receive six million Johnson and Johnson vaccines

CNN  

CNN — Around six million doses of the single-shot Johnson & Johnson coronavirus vaccine will be delivered by the African Union to 27 African nations that have paid for the shipments through the end of August, an AU special envoy said on Thursday. Local vaccine production ‘the answer’ The balance of Africa’s vaccine requirements will come from donors including COVAX, …

Johnson & Johnson\'s single-dose vaccine shows promising signs against Delta variant
3 years, 5 months ago

Johnson & Johnson\'s single-dose vaccine shows promising signs against Delta variant

Deccan Chronicle  

New Jersey: Johnson & Johnson on Thursday announced that its single-shot COVID-19 vaccine showed promising signs of protection against the Delta variant rapidly spreading across the US and other countries, in a small laboratory study. "Today's newly announced studies reinforce the ability of the Johnson & Johnson COVID-19 vaccine to help protect the health of people globally," said Paul Stoffels, …

Johnson & Johnson's COVID Vaccine Is Effective Against The Delta Variant, Studies Find
3 years, 5 months ago

Johnson & Johnson's COVID Vaccine Is Effective Against The Delta Variant, Studies Find

NPR  

Johnson & Johnson's COVID Vaccine Is Effective Against The Delta Variant, Studies Find Enlarge this image toggle caption David Zalubowski/AP David Zalubowski/AP Johnson & Johnson's COVID-19 vaccine offers strong protection against the delta variant of the coronavirus, the company said Thursday. In one small laboratory study, researchers observed what happened to the blood of eight vaccinated individuals when it was …

Covid-19 vaccines in India: Prices and doses to availability, your complete guide
3 years, 5 months ago

Covid-19 vaccines in India: Prices and doses to availability, your complete guide

India Today  

India is slowly but steadily fattening its kitty of Covid-19 vaccines as the country aims to ramp up its vaccination drive. - COVISHIELD - COVAXIN - SPUTNIK V - MODERNA VACCINE A vial of Covishield. However, the Sputnik V vaccine uses two human recombinant adenovirus vectors for its two doses, aimed at providing longer protection. The Moderna vaccine has been …

Johnson & Johnson Covid vaccine likely to be available in India by July
3 years, 5 months ago

Johnson & Johnson Covid vaccine likely to be available in India by July

India Today  

The Covid-19 vaccine developed by Johnson & Johnson will likely be available in India in small quantities by July this year, sources said. Johnson & Johnson’s vaccine could arrive in India as early as July, though it will be limited to a few thousand doses initially. CONCERNS REGARDING J&J VACCINE The US FDA had authorised Johnson & Johnson’s single-dose Covid-19 …

Reliance Foundation Seeks Govt Nod to Import J&J Covid Vaccine Doses for Its Workforce in India
3 years, 6 months ago

Reliance Foundation Seeks Govt Nod to Import J&J Covid Vaccine Doses for Its Workforce in India

News 18  

Reliance Foundation, the philanthropic arm of the Mukesh Ambani-led Reliance Industries, has sought the government’s authorisation to import 20 lakh doses of US-based Johnson and Johnson’s COVID-19 vaccine for captive consumption and to inoculate its workforce pan India, sources said. In a recent communication to the Union Health Ministry, Reliance Foundation has said the imported Johnson and Johnson vaccine will …

In Talks With Pfizer, Johnson & Johnson, and Moderna to Source, Manufacture Vaccines in India: Centre
3 years, 6 months ago

In Talks With Pfizer, Johnson & Johnson, and Moderna to Source, Manufacture Vaccines in India: Centre

News 18  

Discussions are underway with major pharma companies about sourcing and possibly manufacturing their COVID-19 jabs locally while India is looking forward to WHO’s nod for Bharat Biotech’s indigenously developed vaccine, Foreign Secretary Harsh Vardhan Shringla said on Thursday. Addressing the World Health Organisation’s South-East Asia Regional Health Partners’ Forum on COVID-19 he also said the government has worked with key …

India Signs Deal with Domestic Vaccine Maker Biological-E for 300 Mn Doses
3 years, 6 months ago

India Signs Deal with Domestic Vaccine Maker Biological-E for 300 Mn Doses

News 18  

The Centre on Thursday said it has inked a deal with domestic vaccine maker Biological-E for 300 million COVID-19 vaccine doses for 15 billion rupees, the first such order for unapproved shots. Biological E., which also has a separate deal to produce about 600 million doses of Johnson & Johnson's COVID-19 shot annually, said on Tuesday it entered into a …

Second Made-In-India vaccine soon: Centre finalises advance deal with Hyderabad-based firm for 30 crore doses
3 years, 6 months ago

Second Made-In-India vaccine soon: Centre finalises advance deal with Hyderabad-based firm for 30 crore doses

India TV News  

The Union Ministry of Health has finalised arrangements with Hyderabad based vaccine manufacturer Biological-E to reserve 30 crore of COVID-19 vaccine doses. The COVID-19 vaccine of Biological-E is currently undergoing Phase-3 clinical trial after showing promising results in Phase 1 and 2 clinical trials. The arrangement with M/s Biological-E is part of the wider endeavour of government to encourage indigenous …

India in talks with Pfizer, Johnson & Johnson, Moderna to source and locally manufacture Covid-19 vaccines
3 years, 6 months ago

India in talks with Pfizer, Johnson & Johnson, Moderna to source and locally manufacture Covid-19 vaccines

India Today  

The Union government is in talks with major vaccine manufacturers like Pfizer, Johnson & Johnson, and Moderna about sourcing and possible local manufacturing of their vaccines in India, confirmed foreign secretary Harsh Vardhan Shringla on Thursday. Addressing the World Health Organisation's South-East Asia Regional Health Partners' Forum on Covid-19, he said, "We are part of the discussions with major vaccine …

No clinical trials required in India for global Covid vaccines: DCGI
3 years, 6 months ago

No clinical trials required in India for global Covid vaccines: DCGI

India TV News  

Globally available Covid 19 vaccines can now be launched in India without the requirement of post approval clinical trials and testing every batch of the vaccine. The Drugs Controller General of India in a notification has said that vaccines which have been approved for restricted use by US FDA, EMA, UK MHRA and PMDA Japan and under the WHO Emergency …

A Move On Bridging Trials, An Indemnity Suggestion Could Help Covid-19 Vaccine Plan. Here's How
3 years, 6 months ago

A Move On Bridging Trials, An Indemnity Suggestion Could Help Covid-19 Vaccine Plan. Here's How

News 18  

One key step by India’s drug regulator and a hint by government officials could pave the way for faster arrival of foreign Covid-19 vaccines, including those by Pfizer and Moderna, to the country that aims to inoculate all its citizens by December-end. First, the Drug Controller General of India has said post-approval bridging trials and the mandatory testing of every …

COVID diplomacy 2.0, a different order of tasks
3 years, 6 months ago

COVID diplomacy 2.0, a different order of tasks

The Hindu  

Prime Minister Narendra Modi’s words on Buddha Purnima, that in times to come the planet will remember events as either “pre-Covid or post-Covid” could not hold truer than for India’s diplomatic structure worldwide. These include requesting the U.S. to share a substantial portion of its stockpile of AstraZeneca doses and to release more vaccine ingredients which are restricted for exports; …

What's Keeping Pfizer, Moderna's Covid-19 Vaccines Away From India
3 years, 6 months ago

What's Keeping Pfizer, Moderna's Covid-19 Vaccines Away From India

News 18  

It was more than a month back in April that India decided to open its doors to Covid-19 shots that are already in use in selected countries as a severe shortage of the domestically produced Covishield and Covaxin hit the pace of the vaccination drive at a time when India was grappling with a deadly surge of cases. One foreign …

Govt Looking into Securing Part of J&J's Covid Vaccine for Indian Market: Sources
3 years, 6 months ago

Govt Looking into Securing Part of J&J's Covid Vaccine for Indian Market: Sources

News 18  

Johnson and Johnson's COVID-19 vaccine to be manufactured in India by Biological E cannot be directly channelled to the domestic market and will have to be handed over entirely to the US pharma giant as agreed by the firms but the government is looking at the possibility of securing a part of this production, sources said. Hyderabad-based Biological E has, …

UK Insists Covid Vaccines Work Against Variant From India
3 years, 7 months ago

UK Insists Covid Vaccines Work Against Variant From India

News 18  

British Prime Minister Boris Johnson said Wednesday that Covid-19 vaccines are proving effective against a variant that has spread like wildfire in India and denied the government was being lax on travel from hotspots. “We have one of the strongest border regimes anywhere in the world,” he added, after a day of confusion from ministers on Tuesday about whether travel …

US looking at joint production of Johnson and Johnson’s Covid vaccine in India
3 years, 7 months ago

US looking at joint production of Johnson and Johnson’s Covid vaccine in India

Live Mint  

New Delhi: The US is looking at joint production of Johnson and Johnson's COVID-19 vaccine in India and ways to help manufacturers like the Serum Institute of India to boost production, Daniel B Smith, the Charge D'Affaires of the US embassy, said on Tuesday. Last month, the White House said that the US plans to share 60 million doses of …

Discover Related